Ca2+ REGULATION OF SIGNAL TRANSDUCTION IN THE ENDOTHELIUM
W.F. Graier, Austria

APO E: CROSSROADS BETWEEN ALZHEIMER AND ATHEROSCLEROSIS
W. Maerz, Germany

ABCA1, A KEY REGULATOR OF CELLULAR HDL METABOLISM AND MACROPHAGE DIFFERENTIATION
G. Schmitz, Germany

HDL METABOLISM: NEW INSIGHTS INTO THE ROLE OF THE ABC TRANSPORTERS, REVERSE CHOLESTEROL TRANSPORT AND THE DEVELOPMENT OF ATHEROSCLEROSIS
B. Brewer, USA

Coffee Break, Poster Viewing and Exhibition Visit

EPIDEMIOLOGY OF THE METABOLIC SYNDROME
G. Assman, Germany

PHYSIOPATHOLOGY OF THE METABOLIC SYNDROME
J. Chapman, France

TARGETING DIABETES AND THE METABOLIC SYNDROME FOR CHD REDUCTION: A SPECIAL PLACE FOR FIBRATES
S. Robins, USA

COMPARATIVE EFFICACY OF PRAVASTATIN AND FENOFIBRATE IN PRIMARY DYSLIPIDEMIA
J. Ducobu, Belgium

DAIS: TREATMENT OF DYSLIPIDEMIA BEYOND LDL CHOLESTEROL
M.R. Taskinen, Finland

LOW HDL-C RAISING: AN EXPERT PANEL RECOMMENDATION
F. Sacks, USA

J. Chapman, France

CHAIRPERSON'S WELCOME AND INTRODUCTION
J. Chapman, France

UNDERSTANDING THE SCIENCE OF SAFETY
B. Buckley, Ireland

DEVELOPING: AN APPROACH TO PEDIATRICS
J. Kastelein, The Netherlands

FACILITATING HEALTHY AGING
J. Shepherd, UK

MOVING BEYOND GLUCOSE CONTROL IN DIABETES
F. Sacks, USA

PANEL DISCUSSION

CHAIRPERSON'S CLOSE
J. Chapman, France

LIPOPROTEINS AND ENDOTHELIAL CELL FUNCTION. REGULATION OF GENE EXPRESSION
L. Badimon, B. Raposo, C. Rodriguez, Spain

RESTORING THE BALANCE BETWEEN THE ENDOTHELIN SYSTEM AND THE NO SYSTEM IN CORONARY ARTERY DISEASE
T. Neunteufl, Austria

EARLY STATIN THERAPY INDUCES COMPLETE NORMALIZATION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA
S. De Jongh, M.R. Lilien, J. Op 't Roodt, E.S.G. Stroes, H.D. Bakker,
J.J.P. Kastelein, The Netherlands

VITAMIN C REDUCES AORTIC LESION FORMATION AND IMPROVES ENDOTHELIUM-DEPENDENT RELAXATIONS IN ATHEROSCLEROTIC MICE
L.V. D'Uscio, L. Smith, Z.S. Katusic, USA

REGULATION OF ENDOTHELIAL APOPTOSIS BY SHEAR STRESS
X. Jin, M. Mitsumata, T. Yamane, Y. Yoshida, Japan

FATTY ACID-INDUCED ENDOTHELIAL CELL ACTIVATION
B. Hennig, V. Saraswathi, M. Toborek, USA

ISOLATION AND CHARACTERIZATION OF NON-UNIFORM SHEAR STRESS-RESPONSIVE GENES, RECS
H. Nojima, H. Yoshisue, H. Zhao, T. Ohya, S-Y. Kimura, S. Yamashita,
Y. Matsuzawa, Japan

REACTIVE OXYGEN SPECIES AND ANTIOXIDANTS - AN OVERVIEW
B.M. Winklhofer-Roob, Austria

ENDOTHELIUM AND OXIDISED LIPOPROTEINS
A.L. Catapano, A. Pirillo, F. Pellegatta,G.D. Norata, Italy

HIGH-THROUGHPUT FLUORESCENCE SCREENING OF ANTIOXIDANT CAPACITY IN HUMAN SERUM. EFFECTS OF DIETARY FLAVONOIDS ON LIPID AND PROTEIN OXIDATION
A. Hermetter, B. Mayer, Austria

OMAPATRILAT INHIBITS OXIDATIVE STRESS AND ATHEROSCLEROSIS PROGRESSION IN APOLIPOPROTEIN E DEFICIENT MICE
T. Hayek, S. Hamoud, S. Keidar, E. Pavlotzky, R. Coleman, M. Aviram,
M. Kaplan, Israel

MILDLY OXIDISED LDL SUBSPECIES ARE DISTINCT IN THEIR CAPACITY TO INDUCE APOPTOSIS IN ENDOTHELIAL CELLS: ROLE OF LIPID HYDROPEROXIDES
A. Kontush, L. Chancharme, I. Escargueil-Blanc, R. Salvayre,
A. Negre-Salvayre, M.J. Chapman, France

VITAMINS C AND E REDUCE VEGF AND VEGFR-2 EXPRESSION IN APOLIPOPROTEIN E DEFICIENT MICE
B. Nespereira , M. Perez-Ilzarbe, P. Fernandez,J.A. Paramo, J.A. Rodriguez, Spain

IMPLICATIONS OF SNPS AND ETHIC DIVERSITIES IN DIFFERENT GENES RELATED TO THROMBOTIC FACTORS FOR ATHEROSCLEROSIS
A. Ichinose, Japan

FIBRINOLYTIC PARAMETERS AS PROTHROMBOTIC RISK FACTORS IN ATHEROSCLEROSIS: T-PA AND PAI-1
K. Huber, Austria

ROLE OF MATRIX METALLOPROTEINASES, CYSTEINE PROTEASES AND THEIR INHIBITORS IN ATHEROTHROMBOSIS: A MOLECULAR GENETIC APPROACH
A. Hamsten, Sweden

DRASTIC CHOLESTEROL AND FIBRINOGEN REDUCTION IMPROVES LONG-TERM SURVIVAL IN HEART TRANSPLANT RECIPIENTS WITH TRANSPLANT CORONARY ARTERY DISEASE
B.R. Jaeger, M. Oberhoffer, E. Kreuzer, J. Schirmer, P. Ueberfuhr, B. Reichart,
D. Seidel, Germany

FIBRINOGEN PREDICTS ISCHEMIC STROKE AND ADVANCED ATHEROSCLEROSIS, BUT NOT ECHOLUCENT, RUPTURE-PRONE CAROTID PLAQUES
S.C. Kofoed, H.H. Wittrup, H. Sillesen, B.G. Nordestgaard, Denmark

ARE 'STABLE' CAROTID PLAQUES LESS PRONE TO POST-ENDARTERECTOMY MICROEMBOLISATION?
C.W.M. Chan, C. Tiivas, G. Pritchard, D. Higman, C. Imray, UK

THE ADIPOCYTE AS AN ENDOCRINE AND A NO PRODUCING ORGAN
U. Keller, B. Müller, P. Linscheid, Switzerland

OBESITY IN HUMANS: INSIGHT FROM GENETIC STUDIES
W. Patsch, Austria

SECRETORY PRODUCTS OF ADIPOCYTES: THE GOOD PLAYERS VERSUS THE BAD
G. Ailhaud, France

MOLECULAR MECHANISM OF METABOLIC SYNDROME X - IMPORTANCE OF ADIPOCYTOKINES
Y. Matsuzawa, Japan

EFFECTS OF HMG COA REDUCTASE INHIBITOR ON CHOLESTEROL ABSORPTION IN OBESITY : IMPLICATIONS FOR THE REGULATION OF VERY-LOW-DENSITY LIPOPROTEIN B-100 METABOLISM
G.F. Watts, D.C. Chan, P.H.R. Barrett, F.H. O'Neil, G.R. Thompson, Australia, UK

DE NOVO EXPRESSION OF UNCOUPLING PROTEIN-3 IN LIVER IS ASSOCIATED TO A REDUCTION OF BODY WEIGHT GAIN AND ADIPOSITY AFTER FENOFIBRATE TREATMENT OF DIET-INDUCED OBESE RATS
F.P. Mancini, L. Sabatino, A. Lanni, E. Silvestri, R. Franco, G. De Rosa, F. Goglia, V. Colantuoni, Italy

OVERVIEW AND INTRODUCTION TO THE WORKSHOP
D. Seidel, Germany

A NOVEL EXTRACORPOREAL PLASMA DELIPIDATION PROCEDURE FOR THE TREATMENT OF ATHEROSCLEROSIS
K.M. Kostner, J.L. Smith, B.E. Cham, Australia

EXPERIMENTAL AND IN VIVO STIMULATION OF LDL RECEPTOR EXPRESSION IN ATORVASTATIN TREATED PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA BY LDL-IMMUNOAPHERESIS
K. Derfler, M. Jansen, J. Streicher, Austria

A STUDY TO DEMONSTRATE THE UTILITY OF HELP LDL APHERESIS TREATMENT FOR PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME
P.M. Moriarty, C.A. Gibson, K. Flechsenhar, M.S. Mayo, J.L. Vacek, P. Tadros,
S.D. Owens, P. Delafontaine, USA, Germany

ONSET AND SEVERITY OF SUPRAVALVULAR AORTIC STENOSIS DEPEND ON AGE AT BEGINNING OF LDL-APHERESIS IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
S. Gonbert, P. Benlian, E. Bruckert, F. Dairou, I. Atassi, I. Beucler, G. Turpin,
France

LDL-APHERESIS BY IMMUNOADSORPTION WITH 'LDL LIPOPAK' COLUMNS CAN LEAD STABILIZATION AND EVEN REGRESSION OF ATHEROSCLEROTIC PLAQUES IN CORONARY ARTERIES
G.A. Konovalov, A.N. Chebyshev, V.V Kukharchuk, I.Y. Adamova,
O.I. Afanasieva, S.G. Kipor, S.N. Pokrovsky, Russia

LONG-TERM REDUCTION OF C-REACTIVE PROTEIN BY LDL APHERESIS
C. Otto, K. Empen, K.G. Parhofer, Germany

GENETIC ARCHITECTURE OF LIPOPROTEIN(a) TOWARDS THE GLOBAL PICTURE
G. Utermann, Austria

HAS Lp(a) ANY PHYSIOLOGICAL FUNCTION?
G.M. Kostner, Austria

LIPOPROTEIN(a), APO(a) ISOFORMS AND CHD: RESULTS FROM FRAMINGHAM
E.J. Schaefer, USA

LOW MOLECULAR WEIGHT Lp(a) INCREASES THE PAI-1 mRNA TRANSCRIPTION IN BRAIN MICROVASCULAR ENDOTHELIAL CELLS
I. Karadi, J. Skopal, L. Romics, Z. Nagy, Hungary

THE CELLULAR UPTAKE OF LIPOPROTEIN (A) IS MEDIATED BY APOLIPOPROTEIN (A) AND THE LDL RECEPTOR RELATED PROTEIN
E. Schlemmer, H. Scharnagl, M.M. Hoffmann, C. Gschwendner, H. Wieland,
W. Maerz, Germany, Austria

EWA STUDY: EFFECTS OF HORMONE-REPLACEMENT THERAPY ON PLASMA CONCENTRATIONS OF LP(A) LIPOPROTEIN AND TGF-BETA 1
S. Djurovic, A. Westheim, K. Berg, I. Os, Norway

STRUCTURAL FEATURES OF AN APOLIPOPROTEIN B PEPTIDE THAT INHIBITS LIPOPROTEIN(A) ASSEMBLY
R.J. Sharp, R.C. POllock, S.P.A. McCormick, New Zealand